The University of Texas Medical Branch, Galveston
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas Medical Branch, Galveston sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).
The University of Texas Medical Branch, Galveston: 203 sponsored US clinical trials, 29 recruiting.
The University of Texas Medical Branch, Galveston sponsors 203 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 117 completed. 19 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 4 trials.
Top-decile sponsor footprint
The University of Texas Medical Branch, Galveston ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
117 of 157 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
203 total, page 4 of 5
Preserving Muscle Mass and Function in Bedridden Older Adults
NCT01846130
The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue
NCT01661595
Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase II
NCT01694602
Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin
NCT01666665
Pravastatin for Prevention of Preeclampsia
NCT01717586
Amino Acid Supplementation in Recovery From Severe Burns
NCT01618630
Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients
NCT01574131
Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure
NCT01582087
Very Low Density Lipoprotein Turnover in Young and Elderly Individuals
NCT02113215
"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"
NCT01860534
Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly
NCT01384591
Bupropion for Smoking Cessation During Pregnancy
NCT01390246
Hashimotos Thyroiditis and Thyroid Cancer
NCT01428167
Electrical Stimulation and a Dynamic Orthosis for Stroke Recovery
NCT02887872
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
NCT01387659
Effects of a Community Based Exercise Program in Adults With Severe Burns
NCT01184547
Role of Skeletal Muscle Nitric Oxide Production in Age-related Fatigue and Fatigability
NCT01059994
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
NCT01015274
Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
NCT00994669
Adipose Tissue Function After Pancreas Transplantation
NCT01729130
Muscle Mass During Space Exploration
NCT00968344
Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma
NCT00878995
Nutritional and Contractile Regulation of Muscle Growth
NCT00891696
UTMB Research on Severe Asthma (UROSA) Study
NCT02264691
Nutrition and Exercise for Sarcopenia
NCT00872911
Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men
NCT00957801
Coenzyme Q10 in Adult-Onset Ataxia
NCT00957216
Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure
NCT00594009
Menstrual Differences in Airway Inflammation in Asthma
NCT00584441
High-resolution Computed Tomography (HRCT) Evaluation of Airway Distensibility in Lung Transplant Recipients
NCT00584181
Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients
NCT00693173
Physical Work Capacity After Traumatic Brain Injury
NCT00653640
Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
NCT01573754
Improving Adolescent Adherence to Hormonal Contraception
NCT00584038
Cycled Testosterone Replacement Study
NCT00957528
Intervention to Improve Follow-up of Abnormal Pap Test
NCT00575510
Insulin and Sarcopenia in the Elderly
NCT00690534
Response to Phenylketonuria to Tetrahydrobiopterin (BH4)
NCT00244218
A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver
NCT00582400
A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients
NCT00407160
The Use of Clonidine in Pain and Anxiety Associated With Acute Burn Injury in Children
NCT00580151
Soy Isoflavones and Breast Cancer Risk Reduction
NCT00204490
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
NCT00675714
Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
NCT00957671
Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT00075426
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
NCT00012246
Soy Protein and Breast Cancer Risk Reduction
NCT00204477
Assessment of Mechanisms of Improved Wound Healing
NCT00673309
Assessment of Cough Reflex in Lung Transplant Recipients
NCT00584077
Study of Donated Amnion, Fetal Placental Membrane, as Skin Substitute for Burn Patients
NCT00592189
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 24 |
| Phase 2 | 27 |
| Phase 3 | 4 |
| Phase 4 | 15 |
Therapeutic Areas
What is open in the The University of Texas Medical Branch, Galveston pipeline
29 recruiting of 203 indexed (14% open); 117 completed (58%).
Phase mix: 19 late (III/IV) vs 51 early (I/II) (early-phase heavy).
Top condition: Stroke (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Medical Branch, Galveston: open-pipeline peers nationwide
Peers matched on 203 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 203 trials (± recruiting share)
- National Center for Complementary and Integrative Health (NCCIH) · 203 trials · 3% recruiting
- MedImmune · 210 trials · 0% recruiting
- Genzyme, a Sanofi Company · 196 trials · 2% recruiting
- OHSU Knight Cancer Institute · 211 trials · 17% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this The University of Texas Medical Branch, Galveston page
203 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Medical Branch, Galveston or any single study.
- 29 of The University of Texas Medical Branch, Galveston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Medical Branch, Galveston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas Medical Branch, Galveston pipeline card: 203 registered trials from official public datasets.Report a data error.